Pathobiological targets of depression

Bibliography

• Caraci F, Copani A, Nicoletti F, Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 2010;15:64-71
   Google Scholar
• Nestler EJ, Barrot M, DiLeone RJ, Neurobiology of depression. Neuron 2002;34:13-25
   PubMed Web of Science ®Google Scholar
• Shelton RC. The molecular neurobiology of depression. Psychiatr Clin North Am 2007;30:1-11
   PubMed Web of Science ®Google Scholar
• Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008;33:88-109
   PubMed Web of Science ®Google Scholar
• Czeh B, Lucassen PJ. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 2007;257:250-60
   PubMed Web of Science ®Google Scholar
• Wilson RS, Arnold SE, Schneider JA, Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 2006;27:143-53
   PubMed Web of Science ®Google Scholar
• Simard M, Hudon C, van Reekum R. Psychological distress and risk for dementia. Curr Psychiatry Rep 2009;11:41-7
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. American Psychiatric Press, Washington, DC; 1994
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM). 4th edition. Text Revision, American Psychiatric Press, Washington, DC; 2000
   Google Scholar
• Lexis MAS, Jansen NWH, van Amelsvoort L, Depressive complaints as a predictor of sickness absence among the working population. J Occup Environ Med 2009;51:887-95
   PubMed Web of Science ®Google Scholar
• Chentsova-Dutton Y, Hanley K. The effects of anhedonia and depression on hedonic responses. Psychiatry Res 2010;2:176-80
   Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-57
   PubMed Web of Science ®Google Scholar
• Ansorge MS, Hen R, Gingrich JA. Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol 2007;7:8-17
   PubMed Web of Science ®Google Scholar
• Vawter MP, Freed WJ, Kleinman JE. Neuropathology of bipolar disorder. Biol Psychiatry 2000;6:486-504
   Google Scholar
• Schildkraut JJ. Neuropharmacology of the affective disorders. Annu Rev Pharmacol 1973;13:427-54
   PubMedGoogle Scholar
• Schildkraut JJ. The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Psychiatry 1967;3:203-17
   PubMedGoogle Scholar
• Bondy B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 2002;4:7-20
   PubMedGoogle Scholar
• Young LT, Warsh JJ, Kish SJ, Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 1994;35:121-27
   PubMed Web of Science ®Google Scholar
• Delgado PL, Moreno FA. Role of norepinephrine in depression. J Clin Psychiatry 2000;61:5-12
   PubMed Web of Science ®Google Scholar
• Agranoff BW, Cotman CW, Uhler MD. Learning and memory. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors, Basic neurochemistry. Lippincott Williams & Wilkins, Philadelphia; 1998. p. 1027-52
   Google Scholar
• Miller HL, Delgado PL, Salomon RM, Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 1996;53:117-28
   PubMed Web of Science ®Google Scholar
• Neumeister A, Praschak-Rieder N, Willeit M, Monoamine depletion in non-pharmacological treatments for depression. Adv Exp Med Biol 1999;467:29-33
   PubMedGoogle Scholar
• Owens MJ, Krulewicz S, Simon JS, Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. Neuropsychopharmacology 2008;33:3201-12
   PubMed Web of Science ®Google Scholar
• Friedel E, Schlagenhauf F, Sterzer P, 5-HTT genotype effect on prefrontal–amygdala coupling differs between major depression and controls. Psychopharmacology 2009;205:261-71
   PubMed Web of Science ®Google Scholar
• Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994;40:288-95
   PubMed Web of Science ®Google Scholar
• Staley JK, Malison RT, Innis RB. Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 1998;44:534-49
   PubMed Web of Science ®Google Scholar
• Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010;15:18-22
   PubMed Web of Science ®Google Scholar
• Klimek V, Stockmeier C, Overholser J, Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 1997;17:8451-8
   PubMed Web of Science ®Google Scholar
• Frazer A, Hensler JG. Serotonin. In: Siegel GJ, Agranoff BW, Albers L, Fisher DA, Uhler MD, editors, Basic neurochemistry. Lippincott Williams & Wilkins, Philadelphia; 1998. p.263-92
   Google Scholar
• Kuhar MJ, Couceyro PR, Lambert PD. Catecholamines. In: Siegel GJ, Agranoff BW, Albers L, Fisher SK, Uhler MD, editors, Basic neurochemistry: molecular, cellular and medical aspects. Lippincott Williams & Wilkins, Philadelphia; 2001. p. 243-62
   Google Scholar
• Hrdina PD, Bakish D, Ravindran A, Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res 1997;66:73-85
   PubMedGoogle Scholar
• Manji HK, McNamara R, Chen G, Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness. Aust N Z J Psychiatry 1999;33:S65-83
   Web of Science ®Google Scholar
• Yatham LN, Srisurapanont M, Zis AP, Comparative studies of the biological distinction between unipolar and bipolar depressions. Life Sci 1997;61:1445-55
   PubMedGoogle Scholar
• Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999;46:1181-91
   PubMed Web of Science ®Google Scholar
• Coull MA, Lowther S, Katona CLE, Altered brain protein kinase C in depression: a post-mortem study. Eur Neuropsychopharmacol 2000;10:283-8
   PubMedGoogle Scholar
• Duman RS. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998;44:324-35
   PubMed Web of Science ®Google Scholar
• Bernabeu R, Cammarota M, Izquierdo I, Involvement of hippocampal AMPA glutamate receptor changes and the cAMP/protein kinase A/CREB-P signalling pathway in memory consolidation of an avoidance task in rats. Braz J Med Biol Res 1997;30:961-5
   PubMedGoogle Scholar
• Reiach JS, Li PP, Warsh JJ, Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J Affect Disord 1999;56:141-51
   PubMed Web of Science ®Google Scholar
• Krishnan V, Graham A, Mazei-Robison MS, Calcium-sensitive adenylyl cyclases in depression and anxiety: behavioral and biochemical consequences of isoform targeting. Biol Psychiatry 2008;64:336-43
   PubMedGoogle Scholar
• Hines LM, Tabakoff B. Platelet adenylyl cyclase activity: a biological marker for major depression and recent drug use. Biol Psychiatry 2005;58:955-62
   PubMed Web of Science ®Google Scholar
• Green AR. Neuropharmacology of 5-hydroxytryptamine. Br J Pharmacol 2006;147:S145-52
   Google Scholar
• Kiss JP. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression. Neurochem Int 2008;52:34-9
   PubMedGoogle Scholar
• Frodl T, Schule C, Schmitt G, Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007;64:410-16
   PubMed Web of Science ®Google Scholar
• McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007;87:873-904
   PubMed Web of Science ®Google Scholar
• Longone P, Rupprecht R, Manieri GA, The complex roles of neurosteroids in depression and anxiety disorders. Neurochem Int 2008;52:596-601
   PubMedGoogle Scholar
• Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 2008;52:40-51
   PubMed Web of Science ®Google Scholar
• Peng CH, Chiou SH, Chen SJ, Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 2008;18:128-40
   PubMed Web of Science ®Google Scholar
• Shirayama Y, Chen ACH, Nakagawa S, Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002;22:3251-61
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. Why stress is bad for your brain. Science 1996;273:749-50
   PubMed Web of Science ®Google Scholar
• Gould E, McEwen BS, Tanapat P, Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 1997;17:2492-8
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57:925-35
   PubMed Web of Science ®Google Scholar
• Santarelli L, Saxe M, Gross C, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-9
   PubMed Web of Science ®Google Scholar
• Dwivedi Y, Rizavi HS, Conley RR, Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804-15
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116-27
   PubMed Web of Science ®Google Scholar
• Gatt JM, Nemeroff CB, Dobson-Stone C, Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry 2009;14:681-95
   PubMed Web of Science ®Google Scholar
• Berton O, McClung CA, DiLeone RJ, Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006;311:864-8
   PubMed Web of Science ®Google Scholar
• Eisch AJ, Bolanos CA, de Wit J, Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003;54:994-1005
   PubMed Web of Science ®Google Scholar
• Krishnan V, Han MH, Graham DL, Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007;131:391-404
   PubMed Web of Science ®Google Scholar
• Zorner B, Wolfer DP, Brandis D, Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than “depressive”. Biol Psychiatry 2003;54:972-82
   PubMed Web of Science ®Google Scholar
• Monteggia LM, Luikart B, Barrot M, Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007;61:187-97
   PubMed Web of Science ®Google Scholar
• Tanis KQ, Newton SS, Duman RS. Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol Disord Drug Targets 2007;6:151-60
   PubMedGoogle Scholar
• Sen S, Sanacora G. Major depression: emerging therapeutics. Mt Sinai J Med 2008;75:204-25
   PubMed Web of Science ®Google Scholar
• Groves JO. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 2007;12:1079-88
   PubMed Web of Science ®Google Scholar
• Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902
   PubMed Web of Science ®Google Scholar
• Carlezon WA. The many faces of CREB. Trends Neurosci 2005;28:436-45
   PubMed Web of Science ®Google Scholar
• Dwivedi Y, Rizavi HS, Teppen T, Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects. Neuropsychopharmacology 2008;33:2324-40
   PubMed Web of Science ®Google Scholar
• de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005;6:463-75
   PubMed Web of Science ®Google Scholar
• Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985;117:2505-11
   PubMed Web of Science ®Google Scholar
• Swaab DF. The human hypothalamus, basic and clinical aspects. In: Aminoff MJ, Boller F, Swaab DF, editors, Part I: handbook of clinical neurology. Elsevier/North-Holland Biomedical Press, Amsterdam; 2003
   Google Scholar
• Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 2008;57:531-53
   PubMed Web of Science ®Google Scholar
• Aguilera G, Rabadan-Diehl C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 2000;96:23-9
   PubMed Web of Science ®Google Scholar
• McLaughlin KJ, Gomez JL, Baran SE, The effects of chronic stress on hippocampal morphology and function: an evaluation of chronic restraint paradigms. Brain Res 2007;1161:56-64
   PubMed Web of Science ®Google Scholar
• Yu S, Holsboer F, Almeida OF. Neuronal actions of glucocorticoids: focus on depression. J Steroid Biochem Mol Biol 2008;108:300-9
   PubMedGoogle Scholar
• Crochemore C, Lu J, Wu Y, Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 2005;10:790-8
   PubMedGoogle Scholar
• Behl C, Lezoualch F, Trapp T, Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997;138:101-6
   PubMed Web of Science ®Google Scholar
• Elliott EM, Sapolsky RM. Corticosterone enhances kainic acid-induced calcium elevation in cultured hippocampal neurons. J Neurochem 1992;59:1033-40
   PubMed Web of Science ®Google Scholar
• Kawabata K, Kawai Y, Terao J. Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary-adrenal axis response in Wistar rats. J Nutr Biochem 2010;21:374-80
   PubMed Web of Science ®Google Scholar
• Schule C, Baghai TC, Eser D, Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. J Psychiatr Res 2009;43:538-45
   PubMedGoogle Scholar
• Schule C, Baghai TC, Eser D, Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology (Berl) 2006;186:601-11
   PubMed Web of Science ®Google Scholar
• Nikisch G, Mathe AA, Czernik A, Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl) 2005;181:751-60
   PubMedGoogle Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-41
   PubMed Web of Science ®Google Scholar
• Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 2005;29:891-909
   PubMed Web of Science ®Google Scholar
• Kronfol Z. Immune dysregulation in major depression: a critical review of existing evidence. Int J Neuropsychopharmacol 2002;5:333-43
   PubMedGoogle Scholar
• Besedovsky HO, del Rey A, Klusman I, Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem Mol Biol 1991;40:613-18
   PubMed Web of Science ®Google Scholar
• Kim YK, Na KS, Shin KH, Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1044-53
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31
   PubMed Web of Science ®Google Scholar
• Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007;21:9-19
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001;933:222-34
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, O'Brien SM, Scully P, Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med 2006;36:37-43
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Wolf J, Andrassy M, A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003;100:1920-5
   PubMed Web of Science ®Google Scholar
• Sutcigil L, Oktenli C, Musabak U, Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007;2007:76396
   PubMed Web of Science ®Google Scholar
• Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201-17
   PubMed Web of Science ®Google Scholar
• Maes M, Yirmyia R, Noraberg J, The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009;24:27-53
   PubMed Web of Science ®Google Scholar
• Maes M, Song C, Lin A, The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety. Cytokine 1998;10:313-18
   PubMed Web of Science ®Google Scholar
• Ishikawa I, Kitamura H, Kimura K, Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats. Jpn J Vet Res 2001;49:19-25
   PubMedGoogle Scholar
• Bob P, Susta M, Gregusova A, Dissociation, cognitive conflict and nonlinear patterns of heart rate dynamics in patients with unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:141-5
   PubMedGoogle Scholar
• Janelidze S, Mattei D, Westrin S, Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2010 [Epub ahead of print]
   Google Scholar
• O'Brien SM, Scully P, Fitzgerald P, Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 2007;41:326-31
   PubMed Web of Science ®Google Scholar
• Muller N, Schwarz MJ. COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des 2008;14:1452-65
   PubMed Web of Science ®Google Scholar
• Guo JY, Li CY, Ruan YP, Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol 2009;612:54-60
   PubMedGoogle Scholar
• Muller N, Schwarz MJ. Immunological aspects of depressive disorders. Nervenarzt 2007;78:1261-73
   PubMedGoogle Scholar
• Cassano P, Hidalgo A, Burgos V, Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). Pharmacogenomics J 2006;6:381-7
   PubMedGoogle Scholar
• Kaster MP, Ferreira PK, Santos AR, Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 2005;165:204-9
   PubMed Web of Science ®Google Scholar
• Esplugues JV. NO as a signalling molecule in the nervous system. Br J Pharmacol 2002;135:1079-95
   PubMed Web of Science ®Google Scholar
• McLeod TM, Lopez-Figueroa AL, Lopez-Figueroa MO. Nitric oxide, stress, and depression. Psychopharmacol Bull 2001;35:24-41
   PubMedGoogle Scholar
• Joca SR, Guimaraes FS. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 2006;185:298-305
   PubMed Web of Science ®Google Scholar
• Yildiz F, Erden BF, Ulak G, Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl) 2000;149:41-4
   PubMed Web of Science ®Google Scholar
• Spiacci Jr A, Kanamaru F, Guimaraes FS, Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression. Pharmacol Biochem Behav 2008;88:247-55
   PubMedGoogle Scholar
• Harkin A, Connor TJ, Burns MP, Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 2004;14:274-81
   PubMed Web of Science ®Google Scholar
• Harkin A, Connor TJ, Walsh M, Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 2003;44:616-23
   PubMed Web of Science ®Google Scholar
• Miller KJ, Hoffman BJ. Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J Biol Chem 1994;269:27351-7
   PubMedGoogle Scholar
• Galecki P, Maes M, Florkowski A, An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder. Neurosci Lett 2010;486:184-7
   PubMed Web of Science ®Google Scholar
• Galecki P, Maes M, Florkowski A, Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord 2010 [Epub ahead of print]
   Google Scholar
• Heiberg IL, Wegener G, Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behavioural Brain Res 2002;134:479-84
   PubMed Web of Science ®Google Scholar
• Brink CB, Clapton JD, Eagar BE, Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies. J Neural Transm 2008;115:117-25
   PubMedGoogle Scholar
• Trullas R, Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 1990;185:1-10
   PubMed Web of Science ®Google Scholar
• Oliveira RM, Guimaraes FS, Deakin JF. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 2008;41:333-41
   PubMed Web of Science ®Google Scholar
• da Silva FC, do Carmo de Oliveira Cito M, da Silva MI, Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res Bull 2010;83:9-15
   PubMed Web of Science ®Google Scholar
• Irwin SA, Iglewicz A. Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care. J Palliat Med 2010;13:903-8
   PubMed Web of Science ®Google Scholar
• Eren I, Nazroglu M, Demirdas A, Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 2007;32:497-505
   PubMedGoogle Scholar
• Selley ML. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. J Affective Disord 2004;80:249-56
   PubMed Web of Science ®Google Scholar
• Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med 2006;68:1-7
   PubMed Web of Science ®Google Scholar
• Ng F, Berk M, Dean O, Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008;11:851-76
   PubMed Web of Science ®Google Scholar
• Rao JS, Ertley RN, Lee HJ, n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007;12:36-46
   PubMed Web of Science ®Google Scholar
• Bilici M, Efe H, Koroglu MA, Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affective Disord 2001;64:43-51
   PubMed Web of Science ®Google Scholar
• Whanger PD. Selenium and the brain: a review. Nutr Neurosci 2001;4:81-97
   PubMed Web of Science ®Google Scholar
• Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 2004;72:111-27
   PubMed Web of Science ®Google Scholar
• Britt SG, Chiu VW, Redpath GT, Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C, a water solubleanalogue of vitamin E. J Recept Res 1992;12:181-200
   PubMed Web of Science ®Google Scholar
• Capuron L, Neurauter G, Musselman DL, Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment. Biol Psychiatry 2003;54:906-14
   PubMed Web of Science ®Google Scholar
• Wichers MC, Koek GH, Robaeys G, Early increase in vegetative symptoms predicts IFN-alpha induced cognitive-depressive changes. Psychol Med 2005;35:433-41
   PubMedGoogle Scholar
• Myint AM, Kim YK, Verkerk R, Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 2007;98:143-51
   PubMed Web of Science ®Google Scholar
• Hayaishi O, Ishimura Y, Kido R. Biochemical and medical aspects of tryptophan metabolism. Elsevier/North-Holland Biomedical Press, Amsterdam; 1980
   Google Scholar
• Oxenkrug GF. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 2007;1122:35-49
   PubMed Web of Science ®Google Scholar
• Miller CL, Llenos IC, Dulay JR, Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis 2004;15:618-29
   PubMed Web of Science ®Google Scholar
• Musso T, Gusella GL, Brooks A, Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 1994;83:1408-11
   PubMed Web of Science ®Google Scholar
• Sher L, Oquendo MA, Galfalvy HC, Higher cortisol levels in spring and fall in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:529-34
   PubMedGoogle Scholar
• Kaestner F, Hettich M, Peters M, Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affective Disord 2005;87:305-11
   PubMed Web of Science ®Google Scholar
• Chiarugi A, Calvani M, Meli E, Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J Neuroimmunol 2001;120:190-8
   PubMed Web of Science ®Google Scholar
• Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 2002;1:609-20
   PubMed Web of Science ®Google Scholar
• Heyes MP, Saito K, Crowley JS, Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992;115:1249-73
   PubMed Web of Science ®Google Scholar
• Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003;61:519-25
   PubMed Web of Science ®Google Scholar
• Healy D. The three faces of the antidepressants: a ritical commentary on the clinical-economic context of diagnosis. J Nerv Ment Dis 1999;187:174-80
   PubMed Web of Science ®Google Scholar
• Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health 2008;29:115-29
   PubMed Web of Science ®Google Scholar
• Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606
   PubMed Web of Science ®Google Scholar
• Juric DM, Miklic S, Carman-Krzan M. Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes. Brain Res 2006;1108:54-62
   PubMedGoogle Scholar
• Porsolt RD. Animal models of depression: utility for transgenic research. Rev Neurosci 2000;11:53-8
   PubMed Web of Science ®Google Scholar
• Lucki I. A prescription to resist proscriptions for murine models of depression. Psychopharmacology 2001;153:395-8
   PubMedGoogle Scholar
• Katz RJ, Schmaltz K. Dopaminergic involvement in attention.a novel animal model. Prog Neuro-Psychopharmacol 1980;4:585-90
   Google Scholar
• Katz RJ, Hersh S. Amitriptyline and scopolamine in an animal model of depression. Neurosci Biobehav Rev 1981;5:265-71
   PubMed Web of Science ®Google Scholar
• Roth KA, Katz RJ. Further studies on a novel animal model of depression: therapeutic effects of a tricyclic antidepressant. Neurosci Biobehav Rev 1981;5:253-8
   PubMed Web of Science ®Google Scholar
• Willner P, Towell A, Sampson D, Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987;93:358-64
   PubMed Web of Science ®Google Scholar
• Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992;16:525-34
   PubMed Web of Science ®Google Scholar
• Willner P. Animal models as simulations of depression. Trends Pharmcol Sci 1991;12:131-6
   PubMed Web of Science ®Google Scholar
• Bhutani MK, Bishnoi M, Kulkarni SK. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav 2009;92:39-43
   PubMed Web of Science ®Google Scholar
• Kando JC, Wells BG, Hayes PE. Depressive disorders. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors, Pharmacotherapy: a pathophysiologic approach. McGraw-Hill Medical Publishing Group, New York; 2005. p. 1235-56
   Google Scholar